GlassScriptPhysician profile
Richard Jordan Post
NPI 1972504033
$6,464.85
in general payments reported to CMS, 2019-2025
22 companies · $1,845 in 2025
The $1,845 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $30.79 · 2021: $89.43 · 2022: $863 · 2023: $2,906 · 2024: $558 · 2025: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,993 · Travel and Lodging: $1,827 · Consulting Fee: $350 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,993.26 |
| Travel and Lodging | $1,827.30 |
| Consulting Fee | $350.00 |
| Education | $138.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,850.71 | 2023 | |
| Sonex Health, INC. | $1,741.05 | 2022-2025 | Sx-One Microknife |
| Arthrex, INC. | $533.15 | 2025 | |
| Mission Medical Distribution, LLC | $509.13 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $308.18 | 2019-2025 | Exparel, Iovera, Zilretta |
| Anika Therapeutics, INC. | $195.22 | 2024-2025 | Tactoset, Integrity Implant, Revomotion |
| Si-Bone, INC. | $161.33 | 2025 | |
| Amgen INC. | $158.13 | 2023-2025 | Otezla, Evenity |
| Regeneron Healthcare Solutions, INC. | $131.40 | 2023 | |
| Acumed LLC | $128.82 | 2023 | Innate Implant |
| Abbvie INC. | $121.71 | 2025 | |
| Medtronic, INC. | $117.11 | 2025 | Inceptiv |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.42 | 2024 | |
| Stryker Corporation | $80.57 | 2025 | Pangea |
| Endo Pharmaceuticals INC. | $76.83 | 2019-2023 | Xiaflex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $54.27 | 2024-2025 | |
| Radius Health, INC. | $49.55 | 2022 | |
| Ensemble Orthopedics, INC | $41.42 | 2024 | Ensemble Cmc |
| Endo USA, INC. | $36.38 | 2024-2025 | Xiaflex |
| Fidia Pharma USA INC. | $26.10 | 2024 | Hymovis |
| Bioventus LLC | $18.58 | 2020 | |
| Smith+Nephew, INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Post listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.